176 related articles for article (PubMed ID: 15650216)
1. Attenuating mutations of the matrix gene of influenza A/WSN/33 virus.
Liu T; Ye Z
J Virol; 2005 Feb; 79(3):1918-23. PubMed ID: 15650216
[TBL] [Abstract][Full Text] [Related]
2. Introduction of a temperature-sensitive phenotype into influenza A/WSN/33 virus by altering the basic amino acid domain of influenza virus matrix protein.
Liu T; Ye Z
J Virol; 2004 Sep; 78(18):9585-91. PubMed ID: 15331690
[TBL] [Abstract][Full Text] [Related]
3. A live attenuated H1N1 M1 mutant provides broad cross-protection against influenza A viruses, including highly pathogenic A/Vietnam/1203/2004, in mice.
Xie H; Liu TM; Lu X; Wu Z; Belser JA; Katz JM; Tumpey TM; Ye Z
J Infect Dis; 2009 Dec; 200(12):1874-83. PubMed ID: 19909080
[TBL] [Abstract][Full Text] [Related]
4. Synergism of co-mutation of two amino acid residues in NS1 protein increases the pathogenicity of influenza virus in mice.
Pu J; Wang J; Zhang Y; Fu G; Bi Y; Sun Y; Liu J
Virus Res; 2010 Aug; 151(2):200-4. PubMed ID: 20546807
[TBL] [Abstract][Full Text] [Related]
5. Alterations in caspase cleavage motifs of NP and M2 proteins attenuate virulence of a highly pathogenic avian influenza virus.
Zhirnov OP; Klenk HD
Virology; 2009 Nov; 394(1):57-63. PubMed ID: 19747708
[TBL] [Abstract][Full Text] [Related]
6. The compensatory G88R change is essential in restoring the normal functions of influenza A/WSN/33 virus matrix protein 1 with a disrupted nuclear localization signal.
Xie H; Lin Z; Mosier PD; Desai UR; Gao Y
J Virol; 2013 Jan; 87(1):345-53. PubMed ID: 23077315
[TBL] [Abstract][Full Text] [Related]
7. The cold adapted and temperature sensitive influenza A/Ann Arbor/6/60 virus, the master donor virus for live attenuated influenza vaccines, has multiple defects in replication at the restrictive temperature.
Chan W; Zhou H; Kemble G; Jin H
Virology; 2008 Oct; 380(2):304-11. PubMed ID: 18768193
[TBL] [Abstract][Full Text] [Related]
8. A new approach to an influenza live vaccine: modification of the cleavage site of hemagglutinin.
Stech J; Garn H; Wegmann M; Wagner R; Klenk HD
Nat Med; 2005 Jun; 11(6):683-9. PubMed ID: 15924146
[TBL] [Abstract][Full Text] [Related]
9. PB2 amino acid at position 627 affects replicative efficiency, but not cell tropism, of Hong Kong H5N1 influenza A viruses in mice.
Shinya K; Hamm S; Hatta M; Ito H; Ito T; Kawaoka Y
Virology; 2004 Mar; 320(2):258-66. PubMed ID: 15016548
[TBL] [Abstract][Full Text] [Related]
10. Heterologous protection of mice from a lethal human H1N1 influenza A virus infection by H3N8 equine defective interfering virus: comparison of defective RNA sequences isolated from the DI inoculum and mouse lung.
Duhaut SD; Dimmock NJ
Virology; 1998 Sep; 248(2):241-53. PubMed ID: 9721233
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a virus derived from MDCK cells infected persistently with influenza A virus as a potential live-attenuated vaccine candidate in the mouse model.
Liu B; Hossain MJ; Mori I; Kimura Y
J Med Virol; 2008 May; 80(5):888-94. PubMed ID: 18360902
[TBL] [Abstract][Full Text] [Related]
12. Reverse genetics studies of attenuation of the ca A/AA/6/60 influenza virus: the role of the matrix gene.
Sweet TM; Maassab HF; Herlocher ML
Biomed Pharmacother; 2004 Nov; 58(9):509-15. PubMed ID: 15511608
[TBL] [Abstract][Full Text] [Related]
13. Effective small interfering RNAs targeting matrix and nucleocapsid protein gene inhibit influenza A virus replication in cells and mice.
Zhou H; Jin M; Yu Z; Xu X; Peng Y; Wu H; Liu J; Liu H; Cao S; Chen H
Antiviral Res; 2007 Nov; 76(2):186-93. PubMed ID: 17719657
[TBL] [Abstract][Full Text] [Related]
14. Mutations in influenza virus M1 CCHH, the putative zinc finger motif, cause attenuation in mice and protect mice against lethal influenza virus infection.
Hui EK; Smee DF; Wong MH; Nayak DP
J Virol; 2006 Jun; 80(12):5697-707. PubMed ID: 16731908
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen-binding activity of neuraminidase determines the pathogenicity of influenza A virus.
Goto H; Wells K; Takada A; Kawaoka Y
J Virol; 2001 Oct; 75(19):9297-301. PubMed ID: 11533192
[TBL] [Abstract][Full Text] [Related]
16. Characterization of putative defective interfering (DI) A/WSN RNAs isolated from the lungs of mice protected from an otherwise lethal respiratory infection with influenza virus A/WSN (H1N1): a subset of the inoculum DI RNAs.
Noble S; Dimmock NJ
Virology; 1995 Jun; 210(1):9-19. PubMed ID: 7793084
[TBL] [Abstract][Full Text] [Related]
17. The M1 matrix protein controls the filamentous phenotype of influenza A virus.
Elleman CJ; Barclay WS
Virology; 2004 Mar; 321(1):144-53. PubMed ID: 15033573
[TBL] [Abstract][Full Text] [Related]
18. Amino acid changes in the hemagglutinin and matrix proteins of influenza a (H2) viruses adapted to mice.
Govorkova EA; Gambaryan AS; Claas EC; Smirnov YA
Acta Virol; 2000 Oct; 44(5):241-8. PubMed ID: 11252668
[TBL] [Abstract][Full Text] [Related]
19. Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs.
Solórzano A; Webby RJ; Lager KM; Janke BH; García-Sastre A; Richt JA
J Virol; 2005 Jun; 79(12):7535-43. PubMed ID: 15919908
[TBL] [Abstract][Full Text] [Related]
20. Experimental evolution of human influenza virus H3 hemagglutinin in the mouse lung identifies adaptive regions in HA1 and HA2.
Keleta L; Ibricevic A; Bovin NV; Brody SL; Brown EG
J Virol; 2008 Dec; 82(23):11599-608. PubMed ID: 18829764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
